Autotelic Bio is Drug Discovery in South Korea that focus on immuno-oncology drugs business. Founded in 2015. They cover business area such as developer, innovative anti-cancer drug, cancer patient, innovative oncology drug, immuno-oncology drug, therapy, diabetes, hypertension hybrid drug, pain, CNS disease.
2015
( 9 years old in 2024 )
Immuno-oncology Drugs
-
194-41, Osongsaengmyeong 1-ro
Osong-eup, Heungdeok-gu, Cheongju-si
Cheongju-si, Chungcheongbuk-do
South Korea
Private
developerinnovative anti-cancer drugcancer patientinnovative oncology drugimmuno-oncology drugtherapydiabeteshypertension hybrid drugpainCNS disease
* We use standard office opening hours in near Autotelic Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Autotelic Bio is Drug Discovery business from South Korea that founded in 2015 (9 years old in 2024), Autotelic Bio business is focusing on Immuno-oncology Drugs.
Autotelic Bio headquarter office and corporate office address is located in 194-41, Osongsaengmyeong 1-ro Osong-eup, Heungdeok-gu, Cheongju-si Cheongju-si, Chungcheongbuk-do South Korea.
Autotelic Bio was founded in South Korea.
In 2024, Autotelic Bio is currently focus on immuno-oncology drugs sector.
Above is snippet of Google Trends for "immuno-oncology drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Autotelic Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
